patents

Merck loses bid to revive $2.54 billion patent verdict against Gilead
Merck loses bid to revive $2.54 billion patent verdict against Gilead
Yahoo/Reuters
Merck
Gilead Sciences
patents
hepatitis C
Flag link:
Zimmer Biomet Strikes Out at the US Supreme Court Over Hefty Infringement Award
Zimmer Biomet Strikes Out at the US Supreme Court Over Hefty Infringement Award
Medical Devices and Diagnostics Industry
Zimmer Biomet
Stryker
patents
Supreme Court
devices
Pulsavac Plus
Flag link:
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection
Drug Patent Watch
intellectual property
patents
innovation
follow-on
Flag link:
Distorted Drug Patents: Does the U.S. Legal System Steer Researchers Away From Drugs that Take a Long Time to Develop?
Distorted Drug Patents: Does the U.S. Legal System Steer Researchers Away From Drugs that Take a Long Time to Develop?
FDA Law Blog
patents
innovation
drug development
FDA
Flag link:
Why Bausch Health Companies Stock Sank Today
Why Bausch Health Companies Stock Sank Today
Motley Fool
Bausch Health
Novartis
Sandoz
Xifaxan
patents
Flag link:
'I'm quite frankly baffled': Teva's $235M overturn in GSK patent case has judge 'bewildered'
'I'm quite frankly baffled': Teva's $235M overturn in GSK patent case has judge 'bewildered'
Fierce Pharma
Teva Pharmaceutical
GSK
Coreg
patents
Flag link:
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet
Xconomy
patents
Alexion
Amgen
biosimilars
USPTO
Flag link:
Why Mallinckrodt Stock Is Plunging Today
Why Mallinckrodt Stock Is Plunging Today
Motley Fool
Mallinckrodt
opioids
patents
Flag link:
Alexion shares slide on Amgen patent challenge to top-seller
Alexion shares slide on Amgen patent challenge to top-seller
Biopharma Dive
Amgen
Alexion
inter partes review
patents
Soliris
Flag link:
Three strategies for managing loss of exclusivity successfully
Three strategies for managing loss of exclusivity successfully
Pharmaforum
market exclusivity
patents
Humalog
Viagra
Eli Lilly
Pfizer
Flag link:
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Fierce Pharma
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
patents
Praluent
Repatha
Flag link:
Here's Why Mallinckrodt Fell Over 17% Today
Here's Why Mallinckrodt Fell Over 17% Today
Motley Fool
Mallinckrodt
Inomax
patents
Noxivent
Praxair
Flag link:
Lyrica looking grim: Pfizer blockbuster's market share crumbles under generic attack
Lyrica looking grim: Pfizer blockbuster's market share crumbles under generic attack
Fierce Pharma
Pfizer
patents
Lyrica
generics
Flag link:
Biopharma's biggest sellers – the oldies that just keep giving
Biopharma's biggest sellers – the oldies that just keep giving
Evaluate Pharma
Amgen
Enbrel
patents
biologics
Advair
Zantac
Liptor
Plavix
Flag link:
Sanofi defends top oncology drug with Jevtana patent win
Sanofi defends top oncology drug with Jevtana patent win
Fierce Pharma
Sanofi
patents
generics
Jevtana
oncology
Flag link:
Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi
Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi
Pharmaceutical Business Review
Novartis
Sandoz
biosimilars
Amgen
Enbrel
patents
Erelzi
Flag link:
What Enbrel needs to do after its patent win
What Enbrel needs to do after its patent win
EP Vantage
Amgen
Enbrel
patents
generics
Flag link:
Enbrel ruling lifts Amgen shares
Enbrel ruling lifts Amgen shares
BioCentury
Amgen
Enbrel
patents
Sandoz
generics
Flag link:
Lyrica Patent Expiration Ushers In 9 Generic Competitors
Lyrica Patent Expiration Ushers In 9 Generic Competitors
Xtalks
Pfizer
Lyrica
patents
generics
Alembic Pharmaceuticals
Alkem Laboratories
Amneal
Dr Reddy's
InvaGen
MGN Laboratories
Rising Pharmaceuticals
Sciegen Pharmaceuticals
Teva Pharmaceutical
Flag link:
Lyrica generics roll: Pfizer blockbuster finally hits patent cliff
Lyrica generics roll: Pfizer blockbuster finally hits patent cliff
Fierce Pharma
Pfizer
Lyrica
FDA
patents
Flag link:

Pages